Growth inhibitor for leukemia cells comprising antisense oligonucleotide derivative to wilms tumor gene (wt1)
US6277832A · kind A · utility
35Cited by
0References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 20, 2000 |
| Grant date | Aug 21, 2001 |
| Priority date | — |
| Expiry date | Jan 20, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/315
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides a growth inhibitor for leukemia cells comprising an antisense oligonucleotide derivative to Wilms' tumor gene (WT1).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.